Literature DB >> 17427520

Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy.

Yaowaluk Chuapai1, Sasisopin Kiertiburanakul, Kumthorn Malathum, Somnuek Sungkanuparph.   

Abstract

BACKGROUND: Lipodystrophy and dyslipidemia are increasing problems in HIV-infected patients receiving antiretroviral therapy (ART).
OBJECTIVE: Determine the prevalence and predicting factors for lipodystrophy and dyslipidemia in these patients. MATERIAL AND
METHOD: A cross-sectional study was performed on HIV-infected patients receiving ART in January 2006. Clinical assessment for lipodystrophy and blood tests for lipid profile were obtained.
RESULTS: There were 56 patients with a mean age of 42.3 years and 71.4% were male. Lipodystrophy was detected in 66.1%. Baseline characteristics between patients with and without lipodystrophy were similar except for age, history of receiving d4T and undetectable HIV-RNA (p < 0. 05). There was a high prevalence of dyslipidemia (53.6%). By logistic regression, undetectable HIV-RNA (odds ratio (OR) 6.4, p = 0.016) and receiving d4T (OR 7.4, p = 0.022) are predicting factors for lipodystrophy.
CONCLUSION: Lipodystrophy and dyslipidemia in HIV-infected Thai patients receiving ART are common. Clinical monitoring for these abnormalities during ART is highly recommended.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17427520

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).

Authors:  Sang Hoon Han; Jialun Zhou; Suneeta Saghayam; Sasheela Vanar; Nittaya Phanuphak; Yi-Ming A Chen; Thira Sirisanthana; Somnuek Sungkanuparph; Christopher K C Lee; Sanjay Pujari; Patrick C K Li; Shinichi Oka; Vonthanak Saphonn; Fujie Zhang; Tuti Parwati Merati; Matthew G Law; Jun Yong Choi
Journal:  Endocr J       Date:  2011-04-27       Impact factor: 2.349

Review 2.  HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings.

Authors:  Julia L Finkelstein; Pooja Gala; Rosemary Rochford; Marshall J Glesby; Saurabh Mehta
Journal:  J Int AIDS Soc       Date:  2015-01-15       Impact factor: 5.396

3.  Prevalence of Non-AIDS Comorbidities and Factors Associated with Metabolic Complications among HIV-Infected Patients at a Thai Referral Hospital.

Authors:  Chotirat Nakaranurack; Weerawat Manosuthi
Journal:  J Int Assoc Provid AIDS Care       Date:  2018 Jan-Dec

4.  Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting.

Authors:  Somnuek Sungkanuparph; Sasisopin Kiertiburanakul; Anucha Apisarnthanarak; Kumthorn Malathum; Siriorn Watcharananan; Boonmee Sathapatayavongs
Journal:  AIDS Res Ther       Date:  2007-11-21       Impact factor: 2.250

5.  Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.

Authors:  Nazisa Hejazi; Roslee Rajikan; Christopher Lee Kwok Choong; Suzana Sahar
Journal:  BMC Public Health       Date:  2013-08-15       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.